#Nutraceutical Contract Manufacturing Services Market 2024
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Tumblr posted its first advertisements in May 2012 and subsequently earned $13M in revenue.
Text
Nutraceutical Contract Manufacturing Services Market to Hit $275.05 Million by 2032
The global Nutraceutical Contract Manufacturing Services Market was valued at USD 120.6 Million in 2024 and it is estimated to garner USD 275.05 Million by 2032 with a registered CAGR of 12.5% during the forecast period 2024 to 2032.
Are you looking for the Nutraceutical Contract Manufacturing Services Market Research Report? You are at the right place. If you desire to find out more data about the report or want customization, Contact us. If you want any unique requirements, please allow us to customize and we will offer you the report as you want.
The global Nutraceutical Contract Manufacturing Services Market can be segmented on the basis of product type, Applications, distribution channel, market value, volume, and region [North America, Europe, Asia Pacific, Latin America, Middle East, and Africa]. The Nutraceutical Contract Manufacturing Services Industry 2024 report provides a comprehensive overview of critical elements of the industry including drivers, restraints, and management scenarios.
Download Sample PDF: @ https://www.vantagemarketresearch.com/nutraceutical-contract-manufacturing-services-market-2135/request-sample
Top Players
Ashland Glanbia PLC (Ireland), Herbalife International of America Inc. (U.S.), Biotrex Nutraceuticals (India), Martínez Nieto (Spain), Menadione (Spain), Nutra-Science Labs (U.S.)
Trending 2024: Nutraceutical Contract Manufacturing Services Market Report Highlights:
A comprehensive assessment of the parent Industry
Development of key aspects of the business
A study of industry-wide market segments
Evaluation of market value and volume in past, present, and future years
Evaluation of market share
Tactical approaches of market leaders
Innovative strategies that help companies to improve their position in the market
You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/nutraceutical-contract-manufacturing-services-market-2135/0
Analysis Of The Top Companies, Product Types, and Applications In The Market Report:
This report provides sales, revenue growth rate, and verified information about the major players. Also includes a regional analysis and a labor cost analysis, tables, and figures. It also highlights characteristics such as technological growth. The product type segment is expected to continue to maintain its leading position in the future and capture a significant market share based on sales. This report provides analysis, discussion, forecast, and debate on key industry trends, market share estimates, Industry size, and other information. This report also discusses drivers, risks, and opportunities.
Global Nutraceutical Contract Manufacturing Services Market report contains detailed data and analysis on the Nutraceutical Contract Manufacturing Services Market drivers, restraints, and opportunities. Experts with market and industry knowledge as well as research experience from regional experts validate the report. The Nutraceutical Contract Manufacturing Services Market report provides forecast, historical and current revenue for each industry, region, and end-user segment.
Regions Included
-North America [United States, Canada, Mexico]
-South America [Brazil, Argentina, Columbia, Chile, Peru]
-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
-Middle East & Africa [GCC, North Africa, South Africa]
-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
Global Nutraceutical Contract Manufacturing Services Market report data will help you make more informed decisions. For example, in relation to prices, distribution channels are means of marketing or identifying opportunities to introduce a new product or service. These results will also help you make more informed decisions about your existing operations and activities.
Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/nutraceutical-contract-manufacturing-services-market-2135
You Can Use The Nutraceutical Contract Manufacturing Services Market Report To Answer The Following Questions:
What are the growth prospects of the Nutraceutical Contract Manufacturing Services Market business?
Who are the key manufacturers in the Nutraceutical Contract Manufacturing Services Market space?
What Forecast Period for Global Nutraceutical Contract Manufacturing Services Industry Report?
What are the main segments of the global Nutraceutical Contract Manufacturing Services Market?
What are the key metrics like opportunities and market drivers?
The Nutraceutical Contract Manufacturing Services Market Insights
Product Development/Innovation: Detailed Information On Upcoming Technologies, R&D Activities, And Product Launches In The Market.
Competitive Assessment: In-Depth Assessment Of Market Strategies, Geographic And Business Segments Of Key Market Players.
Market Development: Comprehensive Information On Emerging Markets. This Report Analyzes The Market For Different Segments In Different Regions.
Market Diversification: Comprehensive Information On New Products, Untapped Regions, Latest Developments, And Investments In The Nutraceutical Contract Manufacturing Services Market.
Check Out More Reports
Global Remote Patient Monitoring Market: Report Forecast by 2032
Global Vendor Neutral Archive (VNA) and PCAS Market: Report Forecast by 2032
Global Software Defined Wide Area Network Market: Report Forecast by 2032
Global Background Music Market: Report Forecast by 2032
Global Brain Health Supplements Market: Report Forecast by 2032
#Nutraceutical Contract Manufacturing Services Market#Nutraceutical Contract Manufacturing Services Market 2024#Global Nutraceutical Contract Manufacturing Services Market#Nutraceutical Contract Manufacturing Services Market outlook#Nutraceutical Contract Manufacturing Services Market Trend#Nutraceutical Contract Manufacturing Services Market Size & Share#Nutraceutical Contract Manufacturing Services Market Forecast#Nutraceutical Contract Manufacturing Services Market Demand#Nutraceutical Contract Manufacturing Services Market sales & price
0 notes
Text
CPhI India concludes 2021 hybrid edition of CPhI – P-MEC Expo
Informa Pharma Intelligence, one of the business intelligence providers and knowledge partner, concluded its involvement at this year's CPhI & P-MEC Expo, a hybrid conclave hosted between 24 to 26 November 2021 at India Expo Centre – Greater Noida and at the online conference and networking event held between 15 to 30 November 2021.
The conclave witnessed participation from key influencers and leading figures across the pharmaceutical industry, and hosted domestic and foreign drug makers, contract service providers, and pharma machinery players under one roof, providing them with a chance to craft future growth plans together.
Indian pharmaceutical market’s expansion
India's pharmaceutical market is in the midst of a growth spurt, having increased in value from $21bn in 2016 to $29bn in 2020 – a figure that is expected to reach $41bn by 2024. Key industry drivers include a rise in disease prevalence, economic growth and higher disposable incomes, improvements in the healthcare infrastructure, and growth in the number of people covered by health insurance. In a bid to stay afloat during the need to step up the demand towards high quality, low-cost pharma solutions, CPhI & P-MEC India has curated a gateway to network with industry peers for the latest trends and innovative solutions that the market has to offer.
The event is geared towards building pharma community engagements, network amongst the fraternity, and source innovative solutions on-site from exhibitors who have footprints both domestically and globally, and cover the entire pharma supply chain - from APIs, machinery, technology, packaging, outsourcing, finished products and biopharmaceuticals. Alongside the expo, and under the aegis of the India Pharma Week, an exclusive and strategic closed door CEO Roundtable meeting took place, inviting the top leaders of India's pharmaceutical companies. The 'CEO Roundtable' was conducted on 24 November in partnership with Informa Intelligence, whose perspectives and key discussion points will also yield a white paper report.
The pharma industry is anticipated to have a steady growth trajectory and the event organized by CPhI India has focused on the key driving factors for the same. The expansion of medicine manufacturing pertaining to the evolving epidemiological profile of the country will be instrumental for India being the preferred drug manufacturing destination on a global scale. Additionally, the event aims to encourage the development of the research-based pharma fraternity.
Exhibitors at CPhI - P-MEC India 2021
The 2021 edition of the CPhI - P-MEC saw participation from healthcare and pharmaceutical firms from across the country. Auraya Healthcare showcased SVP products in glass vial injections and dilutants; Vital Therapeutics & Formulations showcased its BlendTech range consisting of stabilized and diluted forms of vitamin and vitamin blends for pharmaceutical, nutraceutical, and food products; Osper Formulations exhibited its range of injections; Himedia Laboratories displayed autobio automated mass spectrometry microbial identification system along with culture media and chromogenic media; and MM Pharma exhibited its allopathic and ayurvedic range of softgels, tablets, capsules, sachets, hormones, ointments, diskettes, nutraceuticals and cosmetics.
Spraycel coatings displayed its ready-mix coating materials for tablets; Premier Drug House from Mumbai showcased its pharmaceutical raw materials, vitamins, veterinary bulk drugs, and essential oils; Clara International displayed its range of global packaging solutions; AI-can exports exhibited its Aluminium packaging containers; Proteus Technologies promoted its software for the pharmaceutical firms, and RL Fine Chem promoted its range of narcotics for psychotropic drugs.
The show also had a Belgian stall promoting the Biowin health cluster of Wallonia for export investments. Endofar from Turkey showcased its range of hemp oil and bilberry antioxidant products for pain relief and calming the nerves.
Concluding the CPhI – P-MEC India show, Poornachandra Tejasvi, senior director, Emerging Markets, India, at Informa Pharma Intelligence, said, "We, at Informa Pharma Intelligence, were delighted to witness the overwhelming response at CPhI & P-MEC India 2021 event and we're glad that we could partner with CPhI to host this common platform for the pharmaceutical industry. With challenges and opportunities evolving at a global scale, through this event we looked to discuss the possibilities for not only providing solutions to the healthcare needs of the country but also to the world.
“With India's strength in the global generics market, Indian pharma and biotech companies are now gearing up to transition into R&D and innovation to establish themselves as key players to develop biosimilars, novel chemical entities, novel biological entities, and innovative therapies for the global and Indian pharmaceutical markets, for which Informa Pharma Intelligence is closely partnering to aid in this effort. The event provided a great opportunity to reconnect with our stakeholders of the pharmaceutical world and offer data intelligence and analysis on par with the recent industry trends."
Yogesh Mudras, managing director, Informa Markets in India, said, "The Indian pharmaceutical market is growing exponentially, around twice the world market growth rate. While its generics market is growing strong, it is also evolving into a cradle for new drugs. Therefore, with India being one of the strongest emerging markets in the global pharma industry, it presents great opportunities for all international pharmaceutical companies to explore; we are glad that the platform by CPhI & P-MEC India could enrich the exhibitors with new pharma solutions and help businesses find the right partners, with the hybrid expo showcasing the full drug development supply-chain from exporting, outsourcing, manufacturing, machinery, regulations, pricing, and market access to, packaging, labeling, and digitalization. We look forward to hosting CPhI P-MEC in the coming years again."
0 notes
Text
Empty Capsules Market Is Driven By Geriatric Population, Proliferation Of Pharmaceutical, & Nutraceutical Till 2024
San Francisco, 07 Oct 2019 - The global empty capsules market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.
However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.
Download Full Insight: http://www.grandviewresearch.com/industry-analysis/empty-capsules-market
Further key findings from the study suggest:
In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] For More Information: www.grandviewresearch.com
0 notes
Text
Empty Capsules Market Value $2.57 Billion By 2024
San Francisco, 24 December 2018 – “Empty Capsules Market Analysis By Product (Gelatin, Non-Gelatin Capsules), By Therapeutic Application (Antibiotic & Antibacterial Drugs, Vitamin & Dietary Supplements, Antacids & Anti-flatulent Preparations, Anti-anemic Preparations, Anti-Inflammatory & Anti-rheumatic Drugs, Cardiac Therapy Drugs, Cough & Cold Preparations), By End-user(Pharmaceutical, Nutraceutical, Cosmetics Industries, Research laboratories) And Segment Forecasts To 2024” The global empty capsules market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.
However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.
Browse Research Report On Empty Capsules Market : www.grandviewresearch.com/industry-analysis/empty-capsules-market
Further key findings from the study suggest:
In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.
View more reports of this category by Grand View Research at www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the empty capsules market by product, therapeutic application, end user and region:
Global empty capsules market, by product (USD Million, 2013 - 2024)
Gelatin Capsules
Non-Gelatin capsules
Global empty capsules market by therapeutic application (USD Million, 2013 - 2024)
Antibiotic and antibacterial drugs
Vitamin and dietary supplements
Antacids and antiflatulent preparations,
Antianemic preparations,
Anti-inflammatory and anti-rheumatic drugs,
Cardiac therapy drugs,
Cough and cold preparations
Global empty capsules market by end-user (USD Million, 2013 - 2024)
Pharmaceutical industries
Nutraceutical industries
Cosmeceutical industries
Research laboratories
Empty capsules market, by region (USD Million, 2013 - 2024)
North America
U.S.
Canada
Europe
Germany
UK
Asia Pacific
Japan
China
Latin America
Brazil
Mexico
MEA
South Africa
Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-empty-capsules-market About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
0 notes
Photo
The global D-Amino Acids market is projected to reach US$236.4 million by 2024, driven by its growing role as biologically important organic compounds in pharmaceutical drug production; and emerging new industrial applications. The pharmaceutical industry represents the largest end-use sector, with D-amino acids such as such as D-Cysteine, D-Serine, D-alanine, D-aspartate being major constituents in the manufacture of antibiotics, peptidoglycans, siderophores and surfactins. Significant investments in biomedical and protein engineering is poised to expand the use of d-amino acids in this end-use sector coupled with application expansion supported by breakthrough understanding of the physiological functions of D-amino acids and its metabolic routes for synthesis. Specifically, growing use of D-Cysteine a non-proteogenic sulfur-containing amino acid and D-Serine a non-essential amino acid and dextro isomer of serine, as anti-cancer agents and antibiotics will help spur opportunities for growth in this space. Also benefiting growth is the reviving drug development interest in peptide compounds and molecules which were hitherto widely perceived as ineligible chemical candidates for drug development. In the nutraceuticals sector, consumer desire to maintain healthy lifestyles is helping drive demand for d-amino acid supplements. Of special note is the growing use of D-Tryptophan amino acid in manufacturing of liquid protein weight-loss products. In industrial applications, there is growing investigational interest in the use of D-amino acids as a herbicide resistance gene in herbicide treatment solutions and also as marker genes for the development of transgenic trees. Growing concerns over the use of antibiotic resistance genes in genetically modified plants is driving the focus on alternative, environmentally friendly markers such as D-amino acids based markers. Asia-Pacific represents the largest and the fastest growing market worldwide with a CAGR of 6.8% over the analysis period. The growth in the region is led by factors such as growing generic drug manufacturing activity; rise of pharmaceutical contract manufacturing services; expansion of the manufacturing base and rise in industrial production in developing Southeast Asian economies. More…
For enquiries e-mail us at [email protected] or [email protected]
For cutting edge analyst reviews on top industries Follow us on Twitter, Connect with us on LinkedIn, Follow us on Medium
0 notes
Text
Lyophilization Equipment and Services Market Estimated to Expand at a Robust CAGR by 2024
The global Lyophilization Equipment And Services Market is progressing at an optimistic CAGR of 8.5% from 2014 to 2020. The market was valued at US$2.73 bn 2013. According to a research report released by Transparency Market Research, if the current pace and expected market trends hold true, this market shall reach US$4.8 bn by the end of 2020. This data is given in a report titled “Lyophilization Equipment and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.”
Lyophilization is a process encountered in the pharmaceutical industry as well as in the manufacturing industry of biotech equipment. The process is used to extend the life span of biological products and samples, including vaccines, proteins, blood plasma, antibodies, and enzymes. These are biological materials that are usually extremely sensitive to external changes.
Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1502
According to the TMR report, the global lyophilization equipment and services market currently holds a major driver responsible for its positive growth rate: The increasing risk that pharma companies run regarding the contamination of samples and products. These are often extremely high-value products that are sensitive to external impositions and therefore need a high level of chemical protection. The process of lyophilization itself has undergone several key advancements in terms of technologies used, further boosting this market.
The global lyophilization equipment and services market is also growing due to the increasing number and amounts of commercially available and cost-effective vaccines, due to the growing prevalence of diseases and a growing human population.
The report provides a segmented analysis of the global lyophilization equipment and services market, on the basis of equipment type, services type, applications, and geography.
In terms of equipment type, the market was segmented into freeze drying microscope, rotary lyophilizers, tray lyophilizers, and bench-top lyophilizers. The market was dominated by tray lyophilizers, which held a share of 45% in 2013.
In terms of applications, the global lyophilization equipment and services market was segmented into nutraceuticals, diagnostics, biopharmaceuticals, and pharmaceuticals. It was dominated by the pharmaceuticals segment in 2013.
In terms of services, the market was segmented into bulk lyophilization, aseptic filling, and cycle development.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1502
The geographical examination of the market reveals Europe as being the dominant region in terms of market share in 2013. This region held the top spot owing to the major and novel advancements in technologies in the region, and a medical industry structure that is conducive to highly active clinical trials.
The highest growth rate in the global lyophilization equipment and services market is attributed to Asia Pacific, a fact ascribed to the upswing in contract-based manufacturing activities in Malaysia, India, China, Thailand, and others, along with the increasing availability of a skilled workforce.
The key players in the global lyophilization equipment and services market, as described in the report, include W.L. Gore & Associates, Inc., Thermo Fisher Scientific, Inc., ZIRBUS Technology GmbH, Lyophilization Inc., SP Scientific, LSNE Contract Manufacturing, Biopharma Solutions, Biopharma Technology, Ltd., Aseptic Technologies, and Azbil Telstar, S.L.
Enquiry for discount on this report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1502
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Lyophilization Equipment and Services Market Growth, Trends and Forecast up to 2024
The global lyophilization equipment and services market is primarily driven by a thriving biopharmaceutical industry and rise in contract services, states Transparency Market Research in its latest report. The report is titled “Lyophilization Equipment and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1502
The lyophilization market is estimated to grow from a value of US$2.7 Bn in 2013 to US$4.8 Bn by 2020. Developing healthcare sector in emerging economies and introduction of new technologies is projected to boost the market at an 8.50% CAGR from 2014 to 2020.Lyophilization equipment includes tray lyophilizers, freeze drying microscopes, bench-top lyophilizers, and rotary lyophilizers. Accounting for a share of over 45.0% in 2013, tray lyophilizers dominated the market driven by long-term stability of pharmaceutical products and growing use in large-scale production systems. Lyophilization services include aseptic filling, cycle development, and bulk lyophilization. Bulk lyophilization is the largest and the most rapidly developing service segment and is projected to expand at a 6.50% CAGR from 2014 to 2020.
Lyophilization equipment and services find application in several industries including biopharmaceuticals, nutraceuticals, pharmaceuticals, and diagnostics. The demand for lyophilization equipment and services from the pharmaceutical industry was the highest in 2013 owing to its significant role in the manufacturing division.
Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1502
The worldwide market for lyophilization equipment and services is segmented on the basis of geography into North America, Latin America, Europe, Asia Pacific, the Middle East, and Rest of the World. Europe dominated the global market in 2013, driven by a number of factors such as increase in number of clinical trials, presence of skilled workforce, and development of advanced technologies to enhance product portfolio.
Asia Pacific, on the other hand, is anticipated to be the fastest developing regional segment of the lyophilization equipment and services market. The rapid growth in the region can be attributed to rising adoption of novel technologies, favorable government policies, fast-growing consumer market, presence of skilled labor, and growing scope of contract manufacturing activities in countries such as India, Thailand, China, Malaysia, and Vietnam.
The vendor landscape of the lyophilization equipment and services market is immensely fragmented owing to the presence of several emerging and established biopharmaceutical companies. The leading players contributing towards the growth of the global lyophilization equipment and services market include Irvine Pharmaceutical Services, Biopharma Technology, Ltd., Lyophilization Technology, Inc., Azbil Telstar, S.L., ZIRBUS Technology GmbH, W.L. Gore & Associates, Inc., Aseptic Technologies, BioPharma Solutions, SP Scientific, LSNE Contract Manufacturing, and Thermo Fisher Scientific, Inc. These vendors are analyzed on the basis of company overview, financial standing, recent developments, business strategies, and product portfolio.
Purchase this Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=1502<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Empty Capsules Market Will Be Worth $2.57 Billion By 2024: Grand View Research, Inc.
The global empty capsules market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.
However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.
North America Empty Capsules Market, by Application, 2013 - 2024 (USD Million)
Browse full research report on Empty Capsules Market
Further key findings from the study suggest:
In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.
For more information: http://www.grandviewresearch.com
#Empty Capsules Market#Empty Capsules Market Size#Empty Capsules Market Trends#Empty Capsules Market Share
0 notes
Text
Empty Capsules Market To Exhibit Growth At 6.9% CAGR For Non-Gelatin Capsules Segment Till 2024: Grand View Research, Inc.
The global empty capsules market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.
However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/empty-capsules-market
Further key findings from the study suggest:
· In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
· Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
· In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
· The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
· The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
· Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the empty capsules market by product, therapeutic application, end user and region:
Global empty capsules market, by product (USD Million, 2013 - 2024)
· Gelatin Capsules
· Non-Gelatin capsules
Global empty capsules market by therapeutic application (USD Million, 2013 - 2024)
· Antibiotic and antibacterial drugs
· Vitamin and dietary supplements
· Antacids and antiflatulent preparations,
· Antianemic preparations,
· Anti-inflammatory and anti-rheumatic drugs,
· Cardiac therapy drugs,
· Cough and cold preparations
Global empty capsules market by end-user (USD Million, 2013 - 2024)
· Pharmaceutical industries
· Nutraceutical industries
· Cosmeceutical industries
· Research laboratories
Empty capsules market, by region (USD Million, 2013 - 2024)
· North America
· U.S.
· Canada
· Europe
· Germany
· UK
· Asia Pacific
· Japan
· China
· Latin America
· Brazil
· Mexico
· MEA
· South Africa
Access press release of this research report - http://www.grandviewresearch.com/press-release/global-empty-capsules-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
For more information visit - http://www.grandviewresearch.com/
#Empty Capsules Market#Empty Capsules Market share#Empty Capsules Market growth#Empty Capsules Market forecast#Empty Capsules Market analysis#Empty Capsules Market size
0 notes
Text
Empty Capsules Market Forecasting Include Market Drivers And Restraints, Along With Their Current And Expected Impacts 2013-2024
Global Empty Capsules Market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.
However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.
Full Research Report on Global Empty Capsules Market Analysis: http://www.grandviewresearch.com/industry-analysis/empty-capsules-market
Further key findings from the study suggest:
In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the Global Empty Capsules Market by product, therapeutic application, end user and region:
Global empty capsules market, by product (USD Million, 2013 - 2024)
Gelatin Capsules
Non-Gelatin capsules
Global empty capsules market by therapeutic application (USD Million, 2013 - 2024)
Antibiotic and antibacterial drugs
Vitamin and dietary supplements
Antacids and antiflatulent preparations,
Antianemic preparations,
Anti-inflammatory and anti-rheumatic drugs,
Cardiac therapy drugs,
Cough and cold preparations
Global empty capsules market by end-user (USD Million, 2013 - 2024)
Pharmaceutical industries
Nutraceutical industries
Cosmeceutical industries
Research laboratories
Empty capsules market, by region (USD Million, 2013 - 2024)
U.S.
Canada
Germany
UK
Japan
China
Brazil
Mexico
South Africa
View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-empty-capsules-market
About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more Information visit us: www.grandviewresearch.com
0 notes
Text
Gluten Free Food Market is Estimated to Grow at an approximate CAGR of 10.4% from 2016 to 2024
The growing number of people suffering from celiac disease and with gluten sensitivity is one of the major factors driving the growth in the gluten free food market. The increasing focus on weight management, rising public awareness about the advantages of gluten free food and the change in consumer lifestyle are greatly responsible for the growth in the gluten-free food market.
The NCFA (National Foundation for Celiac Awareness) statistics have specified that 1 in 133 people in the U.S. are suffering from celiac disease among which 80% are diagnosed or misdiagnosed. The growing incidence of diabetes, celiac disease, obesity and other diagnosed food intolerances ailments have positively impacted the growth of the gluten free food market. The increase in demand for ready-to-eat packaged foods and base ingredients has also contributed to the market growth.
The improvement in the product labelling, taste, quality and nutrition in the gluten free food products has led to an increase in the demand for gluten free food. Further, consumers have a variety of options while buying both ready-to-eat packaged goods and base ingredients.
The concept of gluten free food has changed from being medicated products for gluten intolerant people to a lifestyle choice among customers from all segments. New product innovation providing efficient gluten-free food solutions for the ageing population and customized allergen-free products are expected to drive the demand for gluten free food.
The gluten-free food market has been gaining popularity due to a strong retail presence and improved government initiatives in various countries. Supermarkets and departmental stores like Publix, Wegmans, Wal-Mart and Target have separate sections for gluten-free food. Some of the stores have also hire dieticians and nutritionists who would help customers and solve their queries which involve reading food labels, providing food intake guidance and organise store tours. This has greatly improved the sales of the gluten-free food products.
Browse Details of Report @ https://www.hexaresearch.com/upcoming-research/gluten-free-food-market
There is a lack of awareness about gluten-free food products in the developing countries in the Asia-Pacific and Latin America region. It has been observed that consumers are unable to differentiate between intolerance and allergy. Further, the consumers are undiagnosed or misdiagnosed for celiac diseases most of the times. These factors can restrict the growth in the gluten-free food market.
The market is segmented on the basis of type, bakery products, pizzas & pasta, cereals & snacks, savouries, dairy, meat and confectionery products. Bakery products dominated the gluten free food market. This segment includes biscuits, bread, pies, pastries, doughnuts, bread and muffins.
The cereals & snack products segment are expected to grow at the highest growth rate over the forecast period. This is due to the increasing availability of corn, quinoa and sorghum which has led to innovations in the bakery products segment using these gluten free sources in the developed markets of Canada, Italy, Germany and the U.S.
The market is also segmented on the basis of a distribution channel into conventional sources, hotels & restaurants, educational institutions, hospitals & drug stores, and speciality services. The gluten-free food market can also be classified on the basis of source, oilseeds & pulses, rice & corn, dairy & meat products, tuber crops, pseudo-cereals and other cereals.
The gluten-free food market is well developed in North America and Europe. Europe dominates a major part of the market share. The markets in France and Germany are mainly going to contribute to the growth of the European gluten-free food market. It is expected that there will be an increased demand for gluten-free pasta in Germany. Further, consumers are getting attracted to the weight-loss programs which have also led to an increase in the gluten-free food demand.
North America is estimated to experience the fastest growth rate in the gluten-free food market. This is mainly because of the increasing demand for gluten-free diet among the consumers. Asia Pacific and Latin America are predicted to experience a moderate growth due to the lack of product awareness and health benefits of consuming gluten free food products.
The FDA has implemented stringent rules and regulations in the food & beverage market. Manufacturers are boundto comply with regulation stated by the FDA and other authorities. The products with the label ‘gluten-free', ‘no gluten', ‘free of gluten' and ‘without gluten' can contain a maximum gluten limit of 20 parts per million (ppm). The European Union has implemented the same regulation on the gluten-free food products.
The key market players operating in the gluten free food market are Kellogg's Company, Dr Schar, Hain Celestial, Boulder Brands, General Mills and Freedom Foods Group. These companies adopt various strategic initiatives such as mergers & acquisitions, product developments and are engaged in contracts & agreements to boost marketshare.The other important players in the market areKraft Heinz Company and Genius Foods Ltd, Raisio PLC, Valeo Foods, Ener-G Foods andHero Group AG.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/nutraceuticals-and-functional-foods-industry
About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: [email protected]
Read Our Latest Blogs: hexaresearch1.blogspot.com
0 notes
Text
Lyophilization Equipment and Services Market to Witness an Outstanding Growth by 2024
The global Lyophilization Equipment And Services Market is progressing at an optimistic CAGR of 8.5% from 2014 to 2020. The market was valued at US$2.73 bn 2013. According to a research report released by Transparency Market Research, if the current pace and expected market trends hold true, this market shall reach US$4.8 bn by the end of 2020. This data is given in a report titled “Lyophilization Equipment and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.”
Lyophilization is a process encountered in the pharmaceutical industry as well as in the manufacturing industry of biotech equipment. The process is used to extend the life span of biological products and samples, including vaccines, proteins, blood plasma, antibodies, and enzymes. These are biological materials that are usually extremely sensitive to external changes.
Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1502
According to the TMR report, the global lyophilization equipment and services market currently holds a major driver responsible for its positive growth rate: The increasing risk that pharma companies run regarding the contamination of samples and products. These are often extremely high-value products that are sensitive to external impositions and therefore need a high level of chemical protection. The process of lyophilization itself has undergone several key advancements in terms of technologies used, further boosting this market.
The global lyophilization equipment and services market is also growing due to the increasing number and amounts of commercially available and cost-effective vaccines, due to the growing prevalence of diseases and a growing human population.
The report provides a segmented analysis of the global lyophilization equipment and services market, on the basis of equipment type, services type, applications, and geography.
In terms of equipment type, the market was segmented into freeze drying microscope, rotary lyophilizers, tray lyophilizers, and bench-top lyophilizers. The market was dominated by tray lyophilizers, which held a share of 45% in 2013.
In terms of applications, the global lyophilization equipment and services market was segmented into nutraceuticals, diagnostics, biopharmaceuticals, and pharmaceuticals. It was dominated by the pharmaceuticals segment in 2013.
In terms of services, the market was segmented into bulk lyophilization, aseptic filling, and cycle development.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1502
The geographical examination of the market reveals Europe as being the dominant region in terms of market share in 2013. This region held the top spot owing to the major and novel advancements in technologies in the region, and a medical industry structure that is conducive to highly active clinical trials.
The highest growth rate in the global lyophilization equipment and services market is attributed to Asia Pacific, a fact ascribed to the upswing in contract-based manufacturing activities in Malaysia, India, China, Thailand, and others, along with the increasing availability of a skilled workforce.
The key players in the global lyophilization equipment and services market, as described in the report, include W.L. Gore & Associates, Inc., Thermo Fisher Scientific, Inc., ZIRBUS Technology GmbH, Lyophilization Inc., SP Scientific, LSNE Contract Manufacturing, Biopharma Solutions, Biopharma Technology, Ltd., Aseptic Technologies, and Azbil Telstar, S.L.
Enquiry for discount on this report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1502
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Surge in frequency of a range of infectious diseases and chronic conditions drives Empty Capsules Market Growth Over the forecast period
The global Empty Capsules Market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.
However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.
Browse Full Research Report on Empty Capsules Market: http://www.grandviewresearch.com/industry-analysis/empty-capsules-market
Further key findings from the study suggest:
In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.
Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare
Grand View Research has segmented the empty capsules market by product, therapeutic application, end user and region:
Global empty capsules market, by product (USD Million, 2013 - 2024)
Gelatin Capsules
Non-Gelatin capsules
Global empty capsules market by therapeutic application (USD Million, 2013 - 2024)
Antibiotic and antibacterial drugs
Vitamin and dietary supplements
Antacids and antiflatulent preparations,
Antianemic preparations,
Anti-inflammatory and anti-rheumatic drugs,
Cardiac therapy drugs,
Cough and cold preparations
Global empty capsules market by end-user (USD Million, 2013 - 2024)
Pharmaceutical industries
Nutraceutical industries
Cosmeceutical industries
Research laboratories
Empty capsules market, by region (USD Million, 2013 - 2024)
North America
Europe
Asia Pacific
Latin America
MEA
US.
Canada
Germany
UK
Japan
China
Brazil
Mexico
South Africa
Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-empty-capsules-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
0 notes
Text
Empty Capsules Market Forecast Report, Industry Trends To 2024: Grand View Research, Inc.
The global empty capsules market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.
However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/empty-capsules-market
Further key findings from the study suggest:
· In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
· Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
· In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
· The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
· The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
· Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the empty capsules market by product, therapeutic application, end user and region:
Global empty capsules market, by product (USD Million, 2013 - 2024)
· Gelatin Capsules
· Non-Gelatin capsules
Global empty capsules market by therapeutic application (USD Million, 2013 - 2024)
· Antibiotic and antibacterial drugs
· Vitamin and dietary supplements
· Antacids and antiflatulent preparations,
· Antianemic preparations,
· Anti-inflammatory and anti-rheumatic drugs,
· Cardiac therapy drugs,
· Cough and cold preparations
Global empty capsules market by end-user (USD Million, 2013 - 2024)
· Pharmaceutical industries
· Nutraceutical industries
· Cosmeceutical industries
· Research laboratories
Empty capsules market, by region (USD Million, 2013 - 2024)
· North America
· U.S.
· Canada
· Europe
· Germany
· UK
· Asia Pacific
· Japan
· China
· Latin America
· Brazil
· Mexico
· MEA
· South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
For more information visit - http://www.grandviewresearch.com/
0 notes
Text
Empty Capsules Market Size Worth USD 2.57 Billion By 2024: Grand View Research, Inc.
The global empty capsules market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.
However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.
Browse full research report on Electrodes For Medical Devices Market: http://www.grandviewresearch.com/industry-analysis/empty-capsules-market
Further key findings from the study suggest:
In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the empty capsules market by product, therapeutic application, end user and region:
Global empty capsules market, by product (USD Million, 2013 - 2024)
Gelatin Capsules
Non-Gelatin capsules
Global empty capsules market by therapeutic application (USD Million, 2013 - 2024)
Antibiotic and antibacterial drugs
Vitamin and dietary supplements
Antacids and antiflatulent preparations,
Antianemic preparations,
Anti-inflammatory and anti-rheumatic drugs,
Cardiac therapy drugs,
Cough and cold preparations
Global empty capsules market by end-user (USD Million, 2013 - 2024)
Pharmaceutical industries
Nutraceutical industries
Cosmeceutical industries
Research laboratories
Empty capsules market, by region (USD Million, 2013 - 2024)
U.S.
Canada
Germany
UK
Japan
China
Brazil
Mexico
South Africa
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-empty-capsules-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com
#Empty Capsules Market#Empty Capsules Market Size#Empty Capsules Market Analysis#Empty Capsules Market Trends
0 notes
Text
Future Business Opportunities and Key Challenges in Empty Capsules Market 2024
The global empty capsules market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets.
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period.
The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period.
The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies.
In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules.
However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.
To Request for sample copy of this report: http://www.grandviewresearch.com/industry-analysis/empty-capsules-market
Further key findings from the study suggest:
In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd.(Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period.
Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare
Grand View Research has segmented the empty capsules market by product, therapeutic application, end user and region:
Global empty capsules market, by product (USD Million, 2013 - 2024)
Gelatin Capsules
Non-Gelatin capsules
Global empty capsules market by therapeutic application (USD Million, 2013 - 2024)
Antibiotic and antibacterial drugs
Vitamin and dietary supplements
Antacids and antiflatulent preparations,
Antianemic preparations,
Anti-inflammatory and anti-rheumatic drugs,
Cardiac therapy drugs,
Cough and cold preparations
Global empty capsules market by end-user (USD Million, 2013 - 2024)
Pharmaceutical industries
Nutraceutical industries
Cosmeceutical industries
Research laboratories
Empty capsules market, by region (USD Million, 2013 - 2024)
North America
Europe
Asia Pacific
Latin America
MEA
US.
Canada
Germany
UK
Japan
China
Brazil
Mexico
South Africa
Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-empty-capsules-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
0 notes